ArticleFrontiers in oncology2025
Relapsed or refractory central nervous system lymphoma successfully treated by glofitamab combined with lenalidomide.
Yin-Yin Peng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it